Pembrolizumab in mycosis fungoides and Sézary syndrome: Updated results of the CITN multicenter Phase 2 study. (September 2018) - Khodadoust, Michael S.; Rook, Alain H.; Porcu, Pierluigi; Foss, Francine; Moskowitz, Alison; Shustov, Andrei R.; Shanbhag, Satish; Sokol, Lubomir; Fling, Steven P.; Li, Shufeng; Fong, Sophia; Kim, Jinah; et al.